Literature DB >> 2527355

Studies of heterologous promoter trans-activation by the HTLV-II tax protein.

J L Williams1, A J Cann, T Leff, P Sassone-Corsi, I S Chen.   

Abstract

The tax protein of HTLV-II increases the level of steady-state mRNA produced from the HTLV-II long terminal repeat (LTR) and also activates heterologous promoters. We have previously shown that the adenovirus E3 promoter, which is trans-activated by the adenovirus E1a protein, is also trans-activated by the tax protein. To investigate the mechanism of trans-activation by tax, we analyzed E3 promoter deletion mutants to determine nucleotide sequence requirements for activation of this promoter. Our results show that removal of different upstream regions within the promoter does not result in loss of trans-activation, indicating that tax does not appear to interact with a single DNA binding protein to activate the E3 promoter. In addition, tax and E1a together activate the E3 promoter in a greater than additive fashion, suggesting that these proteins function differently. Possible mechanisms of activation by the tax protein are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527355      PMCID: PMC318193          DOI: 10.1093/nar/17.14.5737

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  37 in total

1.  Identification of the putative transforming protein of the human T-cell leukemia viruses HTLV-I and HTLV-II.

Authors:  D J Slamon; K Shimotohno; M J Cline; D W Golde; I S Chen
Journal:  Science       Date:  1984-10-05       Impact factor: 47.728

2.  Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses.

Authors:  M Perricaudet; G Akusjärvi; A Virtanen; U Pettersson
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

3.  Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; T Akagi; Y Ohtsuki; Y Shiraishi; K Nagata; Y Hinuma
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

4.  Molecular characterization of genome of a novel human T-cell leukaemia virus.

Authors:  I S Chen; J McLaughlin; J C Gasson; S C Clark; D W Golde
Journal:  Nature       Date:  1983 Oct 6-12       Impact factor: 49.962

5.  Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells.

Authors:  M Seiki; R Eddy; T B Shows; M Yoshida
Journal:  Nature       Date:  1984 Jun 14-20       Impact factor: 49.962

6.  A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia.

Authors:  V S Kalyanaraman; M G Sarngadharan; M Robert-Guroff; I Miyoshi; D Golde; R C Gallo
Journal:  Science       Date:  1982-11-05       Impact factor: 47.728

7.  Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells.

Authors:  J G Sodroski; C A Rosen; W A Haseltine
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

8.  Binding of host-cell factors to DNA sequences in the long terminal repeat of human T-cell leukemia virus type I: implications for viral gene expression.

Authors:  J K Nyborg; W S Dynan; I S Chen; W Wachsman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

9.  Human T-cell leukemia virus type II transforms normal human lymphocytes.

Authors:  I S Chen; S G Quan; D W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

10.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.